Recent Articles

• Alterity Therapeutics Secures $40 Million for Drug Development
• Don't Miss Orion's Upcoming Capital Markets Day Event!
• Recent Advances in BioRestorative Therapies and BRTX-100
• Grain & Protein Technologies' Strategic Acquisition to Enhance Operations
• ECIPSA Group Expands Horizons with Crystal Lagoons Partnership
• Key Updates and Strategies from RespireRx Pharmaceuticals
• Cohen & Steers Reports High Assets Under Management Growth
• Revolutionizing Patient Referrals: CareCloud's Updated Module
• Flavor Explosion: 7-Eleven's Laredo Taco Company Debuts New Burrito
• Beamr CEO's Insights on Future Video Processing at ACM Event
• Merger of Permascand and Magneto Special Anodes: A New Era
• Emerson's Tender Offer for AspenTech: Key Insights and Benefits
• Bristol Myers Squibb Achieves Breakthrough in Lymphoma Therapy
• Innovative Equipment Showcase by Vac-Con at WWETT Event
• Aben Minerals Successfully Completes Private Placement Funding
• KalVista Pharmaceuticals Unveils Breakthrough Sebetralstat Data
• BCI Sells Majority Stake in Hayfin Capital to Arctos Partners
• Satellos Bioscience Hits Milestone in SAT-3247 Clinical Trial
• Exploring the Rise and Future of Green Hydrogen Markets
• Proton Exchange Membrane Fuel Cells Set to Surge by 2035
• Natera's Latest Guidance on ctDNA Testing in Oncology
• DHG Launches Advanced ASIC Chip for Improved Mining Profitability
• monday.com Unveils Innovative AI Strategy for Future Growth
• Atlantic International Corp. Seals $10 Million Staffing Deal
• Orca Bio's Breakthrough Orca-T® Study Showcases Promising Results
• Breakthrough Therapy: INmune Bio's CORDStrom for RDEB
• Aurion Biotech Welcomes Donald Munoz as New CFO
• Tilray's Growth in the Global Cannabis Market Explained
• Cemex Leadership Transition: New Roles and Future Plans
• Iovance Biotherapeutics Welcomes Dan Kirby as New CCO
• Ziff Davis Set to Unveil Earnings for Fourth Quarter of 2024
• Hydrofarm's Game-Changing Reverse Stock Split Strategy
• Pediatrix Medical Group to Host Conference Call on Q4 Results
• Invivyd's Upcoming Presentation at Oppenheimer Healthcare Event
• Incyte's 2024 Year-End Results and 2025 Milestones Overview
• Recent Developments in Signify's Share Repurchase Program
• Exploration Success at Seahorse Lake Boosts Nickel Interests
• National Seating & Mobility Partners with Ekso Bionics for Innovation
• monday.com Reports Impressive Q4 and FY 2024 Financial Results
• Helium Evolution Highlights Strong Performance from 10-36 Well
• Rockwell Automation Exceeds Expectations in Fiscal Q1 2025
• PyroGenesis Plasma Technology Cuts Energy Use Significantly
• Amicus Therapeutics Reveals Plans for Full-Year Financial Discussion
• BioCryst Pharmaceuticals Plans Fourth Quarter Financial Call
• Hyatt's Strategic Acquisition of Playa Hotels Boosts Portfolio
• Orion Group Holdings Secures $211.7 Million in New Contracts
• Innovative Partnership Between Universal Electronics and Somfy
• Tower Semiconductor's 2024 Financial Performance Deep Dive
• AECOM's Leadership Changes Enhance Global Infrastructure Strategy
• Clearside Biomedical Shares Insights from Recent CLS-AX Study